Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Congress in Poland paves the way for Sensidose

Recently, Sensidose participated in the Polish Neurology Society’s annual science and education conference in Lublin. An increased presence is a strategic step ahead of the planned market launch of the company’s drug Flexilev for the treatment of Parkinson’s disease in Poland. The company’s CEO Jack Spira tells us more about the launch plans in Poland and the learnings from the congress.Read the whole article about Sensidose at biostock.se: https://www.biostock.se/en/2022/09/congress-in-poland-paves-the-way-for-sensidose/ Detta är ett pressmeddelande från BioStock – Connecting

Dignitana Launches DigniCap Direct Partner Portal

Today Dignitana  announces the launch of DigniCap Direct , a partner portal designed to provide added value to healthcare providers and facilitate the direct exchange of information between customers and the company. DigniCap Direct provides a streamlined process for healthcare providers to place orders and easily access DigniCap online training, clinical support, product information, and other account-specific documentation and resources. “Dignitana already has a solid reputation for providing exemplary support and this new

Mycronic receives order for a Prexision 8 Entry Evo

Mycronic AB (publ) has received an order for a Prexision 8 Entry Evo from an existing customer in Asia. The order value is in the range of USD 8-10 million and constitutes Mycronic’s first order for this product. Delivery of the system is planned for the fourth quarter of 2023 and is to replace one of the customer’s older systems.   The Prexision 8 Entry Evo is a new product in the Prexision Evo suite of mask writers for writing photomasks for displays up to G8 mask size. Unlike the Prexision Lite 8 Evo, this model comes with a flexible configuration, which enables customers to

Remedy Entertainment Plc: Publishing time for Q3 2022 Business Review

Remedy Entertainment Plc | Press Release 09:00 a.m. (EEST) September 28, 2022 Publishing time for Q3 2022 Business Review Remedy Entertainment Plc will publish its Business Review for January‒September 2022 on Friday October 28, 2022, at 9:00 a.m. (EEST). Remedy will host a webcast and conference call in English on its financial results for investors, analysts and media on Friday October 28, 2022, at 2:00 p.m. (EEST). Remedy’s Business Review will be presented by CEO Tero Virtala and CFO Terhi Kauppi. The Business Review will be available after publication on Remedy’s Investor

Peab builds production plant in Lund

Peab has been commissioned to build a production plant for pharmaceuticals in Lund. The customer is Wihlborgs Fastigheter AB and the contract is worth SEK 125 million.The building will be located in Hasslanda industrial park and will contain offices, storage, production and tech space. The total area will be 6,400 m2 allocated on two floors and the building will be built according to Miljöbyggnad Silver. “We’re proud to have been entrusted with this construction project that contributes to the continued development of Hasslanda. This is a good example of our locally produced community

Members of the board of directors and executive management subscribe in ongoing rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Brighter AB (publ) (“Brighter” or the “Company”) announces that six members of the board of directors and executive management have subscribed for a combined 690,354 units to a total value of approximately SEK 207 thousand in the ongoing

Alcadon Group decides on new financial targets and Vision 2025

The Board of Directors of Alcadon has decided on new financial targets over a business cycle for the Alcadon Group and Vision 2025. The updated financial targets entail a continued focus on profitable growth both organically and through acquisitions and will take Alcadon to become a well-renowned European premium partner active in carefully selected business areas related to the digitalization of society.During tomorrow's Capital Markets Day, Alcadon will present the company's business model and strategy, product offering, different markets, financial position and Vision 2025, as well as

Skanska builds a new office building and innovation premises in Stockholm for about SEK 800 million

Skanska has signed an agreement with Fabege to build a new office building with associated innovation center for High-speed separators in Flemingsberg, Stockholm. The agreement is worth approximately SEK 800 million, which will be included in the order bookings for Skanska Sweden in the third quarter of 2022.The project is divided into two phases and is carried out in close cooperation between Fabege and Skanska. In 2021, an agreement was signed for phase 1, which included planning participation and production preparations. The second phase, which is now starting, includes the construction

Insplorion focus fully on hydrogen

A review of Insplorion’s business was initiated in connection with the CEO change at the beginning of 2022, and this work has now been completed. The Board and management have now decided that the company needs a stronger focus in its operations regarding business approach and technology development. The new strategic direction of Insplorion can be summarized as follows: · Focus on hydrogen with a maintained instrument business, down-prioritize areas where the right technology and market conditions are unfavorable · Prove the technology in customer financed hydrogen projects and

General update Axolot Solutions - The positive development continues despite a challenging situation in the world

Since we published our latest interim report, the Axolot team has continued working at full speed. Despite all challenges we see in the world, we strongly believe that Axolot is developing in the right direction and the expectations we put on ourselves are high. Our intention with this update is twofold; primarily to fill the time gap that may arise between the more formal press releases we publish and secondly to make sure that shareholders and other interested parties are provided with a somewhat broader information about the progress in and around Axolot right now, as well as the direction

Metso Outotec wins an order for a large iron-ore pelletizing plant in China

Metso Outotec Corporation’s press release on September 28, 2022, at 09:00 a.m. EESTMetso Outotec has signed a contract with Beijing Shougang International Engineering Technology Co. Ltd. (BSIET) for the delivery of an iron-ore pelletizing plant to Shougang Qian’an Iron and Steel Co. Ltd. The plant will be built in Qian’an, Hebei province in China. The order value, which is not disclosed, is booked into Metals’ third-quarter orders received.Metso Outotec’s scope of delivery includes the engineering and design of the indurating system and process gas fan system, as well as supply of

Photocure Announces the Commercial Availability of Karl Storz’s New Blue Light System in the U.S.

Karl Storz and Photocure to collaborate on commercializing the high-definition system Press Release – Oslo, Norway, September 28, 2022: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the commercial availability of Karl Storz’s New Blue Light equipment powered by Saphira™ in the U.S. As part of the rollout, Karl Storz plans to host a Virtual Launch event for the medical community streamed from its El Segundo, California office where Sia Daneshmand M.D. and Kristin Scarpato M.D. M.P.H. will discuss the clinical benefits of using BLC[®] with Cysview[® ]for NBMIC*, while

NCC expands electricity supply in southern Stockholm

NCC has now commenced the refurbishment of one of Stockholm’s oldest national grid stations in Hammarby Sjöstad. The new main distribution station will have increased capacity and pave the way for the development of southern Stockholm. The project is a turnkey contract in partnering form on behalf of Ellevio. Genre image: NCC In Hammarby Sjöstad, NCC is building a new modern main distribution station that will house a 220 kV gas-insulated switchgear. The refurbishment of this station will increase the output of Stockholm’s electricity grid, which is a prerequisite for continued

Silicon Valley Bank UK strengthens its Nordic presence by expanding into Sweden

Maria Ljungberg, country Director Silicon Valley Bank in Sweden Photo: Olof Ehrs   London: 28 September 2022 – Silicon Valley Bank UK, the bank of the world’s most innovative companies and investors, today announced that it has expanded its Nordic footprint and established a representative office in Stockholm, Sweden. This will support the needs of Swedish innovation businesses and their investors within the technology and life science sectors.  Silicon Valley Bank UK has chosen to establish a presence in Sweden, building on the strong ecosystem for entrepreneurs and

Teachers’ turnover intentions, burnout and poor work climate are interlinked

The risk of burnout and poor experienced teacher-working environment fit is increased among teachers with persistent turnover intentions. However, positive experiences in the workplace seem to protect against cynicism and exhaustion, according to a new study from Finland.Teachers’ turnover intentions, burnout symptoms and poor experienced teacher-working environment fit are interlinked, and therefore also likely to occur simultaneously. If a teacher experiences one of the above, the risk of experiencing others increases, too. The researchers explored experienced burnout and teacher-

M.O.B.A. Network acquires LoLwiz - an "in-game app" for League of Legends

M.O.B.A. has entered into an agreement to acquire LoLwiz, one of the largest in-game applications for League of Legends. The acquisition strengthens M.O.B.A's position and offer for League of Legends players and opens up a new business area for in-game ads within the group. LoLwiz is an application that seamlessly integrates with the game League of Legends and provides the player with real-time tips during the game. LoLwiz  is distributed via the largest platform for in-game applications, Overwolf . LoLwiz is monitized via in-game

Lecanemab phase 3 Clarity AD study in early Alzheimer’s disease meets primary and all key secondary endpoints with high statistical significance

Stockholm, September 28, 2022 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced positive topline results for the large global Phase 3 confirmatory Clarity AD study in 1,795 subjects. The study met the primary endpoint (CDR-SB[1]: Clinical Dementia Rating-Sum of Boxes) showing a highly statistically significant reduction of clinical decline. All key secondary endpoints were also met demonstrating highly statistically significant results. Clarity AD is a clinical trial of lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Aβ) protofibril

ShaMaran’s 2023 Bond Exchanged for 2025 Bond and Accrued Interest Paid in Full

VANCOUVER, BC, September 27, 2022 /CNW/ - ShaMaran Petroleum Corp. (“ShaMaran” or the “Company”) (SNM: TSXV and Nasdaq First North Growth Market (Sweden)) is pleased to announce that, following the closing of the Sarsang acquisition and in accordance with the Bond Terms between ShaMaran and Nordic Trustee as bond trustee for the 2025 12% senior unsecured bond (ISIN NO 0011057622) entered into on July 30, 2021 and previously announced, the Company’s 2023 12% senior unsecured bond (ISIN NO 0010826456) has today been exchanged for its 2025 bond and accrued interest has been paid in full as at

Eco Wave Power Presents Continued Operational Progress and Reports First Half 2022 Financial Results

The Company is Gearing Towards the Official Opening of its Project in Israel, while Also Creating a Strong U.S Presence through its Upcoming Pilot at the Port of Los Angeles, and its Progress in Promoting the First Onshore Wave Energy Implementation in the State of New Jersey. At the Same Time, Eco Wave Power is Reinforcing its European Presence with Planned Projects in Portugal and Spain, with a Clear Goal of Moving Towards Larger Scale Deployments.Stockholm, Sweden, September 27, 2022 – Eco Wave Power Global AB (publ) (“Eco Wave Power” or the “Company”) (Nasdaq: WAVE), a leading, publicly

Nordea Bank Abp: Repurchase of own shares on 27.09.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares27.09.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 27.09.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XHEL 677,313 9.22 6,244,216.28CEUX 407,016 9.20 3,746,438.90TQEX 54,972 9.20 505,535.99XSTO 320,213 9.18 2,

Multiconsult ASA - Share buyback

Multiconsult ASA (OSE: MULTI) announced on 19. September 2022 a non-discretionary agreement with ABG Sundal Collier for the repurchase of up to 500,000 of its ordinary shares in the market in connection with its employee share purchase programme in 2022.From 19. September 2022 until 27. September 2021, Multiconsult ASA has purchased a total of 19,298 own shares at Oslo Børs at an average price of NOK 134.8408 per share. Aggregated overview of transactions per day: Overview oftransactionsDate Aggregated daily Weighted average Total daily volume (

New Hearts of Iron IV Expansion Available Now

By Blood Alone Add-On Includes Plane Designer and New Alternate HistoriesSTOCKHOLM - 27 September 2022 - Paradox Interactive’s best-selling grand strategy wargame Hearts of Iron IV gets even grander and more strategic today with the release of By Blood Alone, a new expansion pack that adds new ways to explore the limits of your military genius and long-term planning. The centerpieces of By Blood Alone include the much requested aircraft designer, allowing you to build the fighters and bombers of your imagination, and three new national focus trees, carving out room for an even wider

AcuCort receives marketing authorization for the drug Zeqmelit by the Norwegian Medicines Agency

AcuCort AB (publ) (Spotlight Stock Market: ACUC) today announces that the Norwegian Medicines Agency, Statens legemiddelsverk, has approved the company’s first drug under the name Zeqmelit in Norway.In the development of the drug Zeqmelit/ISICORT[®], AcuCort has managed to combine the benefits of the well-proven substance dexamethasone and the patented user-friendly oral film for quick availability and relief in emergency situations such as severe and acute allergic reactions. The drug was recently approved in Denmark under the name Zeqmelit and has previously been approved in Sweden

As previously communication, Brighter's subsidiary Nectarine Health has now submitted an application for corporate restructuring

Brighter AB (Publ) (“Brighter”) announces that its subsidiary Pink Nectarine Health AB (“Nectarine Health”) has today, as communicated in a press release from September 23 2022 , submitted an application for corporate restructuring (Sw. “företagsrekonstruktion”) to the Stockholm District Court. The decision follows from a liquidity shortfall in Nectarine Health and is deemed necessary to give Nectarine Health the time required to

There are no items matching the current filter
There are no more items matching the current filter
Back to top